Cover Image

Factors Associated With Coverage in Community-directed Treatment With Ivermectin for Onchocerciasis Control in Savanah and Forest Areas in Central African Republic: A Cross-sectional Study

Objectives: The aim of this study was to identify factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in savannah and forest areas in the Central African Republic. Methods: A cross-sectional study was conducted in 2 districts where onchocercias...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sylvain Honoré Woromogo (Author), Stéphanie Inesse Garoua-Adjou (Author), Ange Donatien Ngouyombo (Author), Rodrigue Herman Doyama-Woza (Author), Henri Saint Calvaire Diemer (Author), Jean de Dieu Longo (Author)
Format:	Book
Published:	Korean Society for Preventive Medicine, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Incidence and risk factors for tuberculosis among people living with HIV in Bangui: A cohort study
by: Jean De Dieu Longo, et al.
Published: (2022)

Risk factors for multidrug-resistant tuberculosis in the Central African Republic: A case-control study
by: Jean de Dieu Longo, et al.
Published: (2023)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: Winnen M., et al.
Published: (2002)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
by: Raphael Awah Abong, et al.
Published: (2021)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023)

Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators.
by: Natalie V S Vinkeles Melchers, et al.
Published: (2024)

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
by: Lamine Diawara, et al.
Published: (2009)

Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
by: Kathrin Arndts, et al.
Published: (2014)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
by: Mariella Anselmi, et al.
Published: (2015)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020)

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
by: Mamadou O Traore, et al.
Published: (2012)

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
by: Stanimira P Krotneva, et al.
Published: (2015)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019)

Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2023)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018)

A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.
by: Frank O Richards, et al.
Published: (2016)

Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
by: Arnauld Efon-Ekangouo, et al.
Published: (2023)

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2024)

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon
Published: (2024)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
by: Nicholas O Opoku, et al.
Published: (2023)

Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
by: Christian Tetteh Duamor, et al.
Published: (2017)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
by: Gasim Abd-Elfarag, et al.
Published: (2018)

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
by: Saskia I Johanns, et al.
Published: (2022)

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
by: Bruno P. Mmbando, et al.
Published: (2018)

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo
by: Saskia I. Johanns, et al.
Published: (2022)

Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia
by: Gebremedhin Gebrezgabiher, et al.
Published: (2020)

Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
by: Olusola Ojurongbe, et al.
Published: (2015)

Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
by: Linda Djune-Yemeli, et al.
Published: (2022)

Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
by: Samuel Wanji, et al.
Published: (2018)